pharmaceuticals

Pharmalot By Ed Silverman

Drugmakers win court battle over an HHS rule that would have penalized them for offering copay coupons

Pharmalot By Ed Silverman

‘Pharma bro’ Martin Shkreli released from prison

First Opinion By Paul Fenyves

Does Paxlovid help people who have been vaccinated against Covid-19? Show us the data!

Pharmalot By Ed Silverman

Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds

Pharmalot By Ed Silverman

High blood pressure pills are costly — but also hard to find — in some lower-income countries

Pharmalot By Ed Silverman

Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge

Pharmalot By Ed Silverman

Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic

D.C. Diagnosis By Nicholas Florko

Pharma showers John Thune with campaign cash

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

First Opinion By Brian Barnett

Flawed FDA safety requirements are hamstringing a highly effective treatment for severe schizophrenia

Health Tech By Mohana Ravindranath

A clash over online Adderall prescriptions is raising new questions about telehealth

Pharmalot By Ed Silverman

California fines an OptumRx pharmacy for jeopardizing patient health. Is that enough?

Biotech By Matthew Herper

With new diabetes drug data, Eli Lilly is taking aim at obesity

Health By Matthew Herper

Biden administration starts Covid treatment push, focusing on Pfizer’s Paxlovid

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

U.S. spending on pharmaceuticals jumped 12% in 2021, fueled by costs of Covid-19 vaccines and therapies

Opinions+ By Scott Swain, Kristin M. Zimmerman Savill and Bruce Feinberg

Pharma’s role in value-based care starts with value-based research

First Opinion By Bernard Zipprich

Will the shadow of Aduhelm cloud FDA’s decision-making on an ALS therapy?

Pharmalot By Ed Silverman

Endo wins a reprieve in an opioid lawsuit in Tennessee as appeals court overturns sanctions

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs

Biotech By Jonathan Wosen

Halozyme to acquire Antares for nearly $1B in bid to dominate drug delivery market

Biotech By Adam Feuerstein

Good fortunes continue for Sierra Oncology with $1.9 billion acquisition by U.K. pharma giant Glaxo

Pharmalot By Ed Silverman

Pharma pledges faster drug launches in Europe in hopes of avoiding stricter regulations

Pharmalot By Ed Silverman

FDA scolds Bausch Health for misleading claims about a psoriasis cream